Liminal BioSciences Inc. LMNL
8.50 +8.50
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 401.00K | 643.00K | 724.00K | 745.00K | 24.63M | |
| 401.00K | 643.00K | 724.00K | 745.00K | -1.07M | |
| -32.76M | -49.97M | -47.22M | -53.55M | -265.33M | |
| 744.00K | 11.54M | -119.59M | -207.80M | -280.43M | |
| 0.16 | 4.27 | -48.25 | -128.10 | -2,359.50 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 37.14M | 108.49M | 45.08M | 61.28M | 7.39M | |
| 50.46M | 126.05M | 117.78M | 165.10M | 102.89M | |
| 14.25M | 92.17M | 102.77M | 70.16M | 166.04M | |
| 1.49M | 60.78M | 73.98M | 47.07M | 127.65M | |
| 36.21M | 42.64M | 23.10M | 102.19M | -56.60M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -31.82M | -99.60M | -75.92M | -99.39M | -82.45M | |
| 3.82M | 170.69M | 2.31M | 36.10M | -5.86M | |
| -45.45M | -8.42M | 57.41M | 117.92M | 72.16M | |
| 3.16M | -411.00K | -1.91M | -4.44M | -5.13M | |
| -73.45M | 62.66M | -16.21M | 54.63M | -16.16M |